bladder cancer

JNJ
Pharma

J&J's intravesical bladder cancer therapy Inlexzo lands FDA nod

The product is approved to treat patients with bladder cancer who face removal of the organ after not responding to the standard first-line treatment.
Zoey Becker Sep 10, 2025 10:50am
Tecentriq

Roche touts Tecentriq biomarker win in bladder cancer

Aug 18, 2025 4:17pm
newspaper

Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia

Aug 15, 2025 8:31am
Graphic of a dart right on a bullseye sun breaking through the clouds in the background

Padcev-Keytruda combo delivers bladder cancer 'breakthrough'

Aug 12, 2025 11:16am
picture of a green light

FDA signs off on UroGen's Zusduri after advisory committee snub

Jun 13, 2025 8:56am
sustainability green goals

Pfizer partner touts HER2 ADC trial win in bladder cancer

May 12, 2025 10:59am